Loading clinical trials...
Loading clinical trials...
A Phase 3, Prospective, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus Eluting Collagen Implant (The ACCESS 2 Trial)
Conditions
Interventions
Sirolimus
Locations
22
United States
Veterans Affairs San Diego Health Center
San Diego, California, United States
Lundquist Institute for Biomedical Innovation
Torrance, California, United States
MedStar Cardiovascular Research Network at MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
American Access Care of Miami
Miami, Florida, United States
Emory University Hospital Midtown
Atlanta, Georgia, United States
Augusta University
Augusta, Georgia, United States
Start Date
August 26, 2022
Primary Completion Date
March 18, 2025
Completion Date
August 29, 2025
Last Updated
September 24, 2025
NCT07157397
NCT06326905
NCT07020832
NCT07153939
NCT07146854
NCT04163614
Lead Sponsor
Vascular Therapies, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions